99% Savings - Buy Just @1 Rs X
Olmesafe H 12.5/40 Tablet is a commercial drug that is prescribed in the form of Tablet. The alternative uses of Olmesafe H 12.5/40 Tablet have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Olmesafe H 12.5/40 Tablet. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
Common side effects of Olmesafe H 12.5/40 Tablet include Upper respiratory tract infection. Some other side effects of Olmesafe H 12.5/40 Tablet have been listed ahead. Such side effects of Olmesafe H 12.5/40 Tablet normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
Olmesafe H 12.5/40 Tablet's effect during pregnancy is Severe and Mild while nursing. It is important to know if Olmesafe H 12.5/40 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Olmesafe H 12.5/40 Tablet related warnings section.
Olmesafe H 12.5/40 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Olmesafe H 12.5/40 Tablet in conditions like Asthma, Allergy, Kidney Disease. The section on Olmesafe H 12.5/40 Tablet contraindications lists all such conditions.
Additionally, Olmesafe H 12.5/40 Tablet may also adversely react with other medicines. See below for a complete list.
In addition to the above precautions for Olmesafe H 12.5/40 Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Olmesafe H 12.5/40 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Olmesafe H 12.5/40 Tablet safe for pregnant women?
Olmesafe H has many dangerous side effects in pregnant women. If you are pregnant, do not consume Olmesafe H without medical advice.
Is the use of Olmesafe H 12.5/40 Tablet safe during breastfeeding?
Olmesafe H has been seen to have minimal side effects on breastfeeding women.
What is the effect of Olmesafe H 12.5/40 Tablet on the Kidneys?
Olmesafe H may have mild side effects on the kidneys.
What is the effect of Olmesafe H 12.5/40 Tablet on the Liver?
Olmesafe H is rarely harmful for the liver.
What is the effect of Olmesafe H 12.5/40 Tablet on the Heart?
Olmesafe H has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Olmesafe H 12.5/40 Tablet unless your doctor advises you to do so -
Is this Olmesafe H 12.5/40 Tablet habit forming or addictive?
Forming a habit of Olmesafe H 12.5/40 Tablet has not been reported.
Interaction between Food and Olmesafe H 12.5/40 Tablet
Olmesafe H 12.5/40 Tablet may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Olmesafe H 12.5/40 Tablet
Consuming Olmesafe H 12.5/40 Tablet with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hydrochlorothiazide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 582-586
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173